KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Return on Sales (2019 - 2025)

Historic Return on Sales for Castle Biosciences (CSTL) over the last 8 years, with Q3 2025 value amounting to 0.01%.

  • Castle Biosciences' Return on Sales fell 300.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.05% for FY2024, which is 3200.0% up from last year.
  • According to the latest figures from Q3 2025, Castle Biosciences' Return on Sales is 0.01%, which was down 300.0% from 0.05% recorded in Q2 2025.
  • Castle Biosciences' 5-year Return on Sales high stood at 0.11% for Q4 2024, and its period low was 0.92% during Q1 2022.
  • Moreover, its 5-year median value for Return on Sales was 0.19% (2021), whereas its average is 0.24%.
  • In the last 5 years, Castle Biosciences' Return on Sales tumbled by -7300bps in 2022 and then surged by 6600bps in 2024.
  • Quarter analysis of 5 years shows Castle Biosciences' Return on Sales stood at 0.26% in 2021, then tumbled by -109bps to 0.54% in 2022, then soared by 93bps to 0.04% in 2023, then skyrocketed by 385bps to 0.11% in 2024, then plummeted by -105bps to 0.01% in 2025.
  • Its Return on Sales stands at 0.01% for Q3 2025, versus 0.05% for Q2 2025 and 0.29% for Q1 2025.